256 related articles for article (PubMed ID: 20160059)
21. Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer.
Toyonaga T; Nakano K; Nagano M; Zhao G; Yamaguchi K; Kuroki S; Eguchi T; Chijiiwa K; Tsuneyoshi M; Tanaka M
Cancer Lett; 2003 Nov; 201(1):107-16. PubMed ID: 14580692
[TBL] [Abstract][Full Text] [Related]
22. Novel thiosemicarbazones regulate the signal transducer and activator of transcription 3 (STAT3) pathway: inhibition of constitutive and interleukin 6-induced activation by iron depletion.
Lui GY; Kovacevic Z; V Menezes S; Kalinowski DS; Merlot AM; Sahni S; Richardson DR
Mol Pharmacol; 2015; 87(3):543-60. PubMed ID: 25561562
[TBL] [Abstract][Full Text] [Related]
23. Novel mechanism of aberrant ZIP4 expression with zinc supplementation in oral tumorigenesis.
Ishida S; Kasamatsu A; Endo-Sakamoto Y; Nakashima D; Koide N; Takahara T; Shimizu T; Iyoda M; Shiiba M; Tanzawa H; Uzawa K
Biochem Biophys Res Commun; 2017 Jan; 483(1):339-345. PubMed ID: 28017725
[TBL] [Abstract][Full Text] [Related]
24. Effects of IL-6 and AG490 on regulation of Stat3 signaling pathway and invasion of human pancreatic cancer cells in vitro.
Huang C; Yang G; Jiang T; Huang K; Cao J; Qiu Z
J Exp Clin Cancer Res; 2010 May; 29(1):51. PubMed ID: 20482858
[TBL] [Abstract][Full Text] [Related]
25. [
Fang Y; Wang S; Yang Q; You S; Xing X
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jun; 42(6):905-912. PubMed ID: 35790442
[TBL] [Abstract][Full Text] [Related]
26. CREB participates in the IGF-I-stimulation cyclin D1 transcription.
Yan Y; Li X; Kover K; Clements M; Ye P
Dev Neurobiol; 2013 Aug; 73(8):559-70. PubMed ID: 23447091
[TBL] [Abstract][Full Text] [Related]
27. Neuropilin-1 (NRP-1) upregulated by IL-6/STAT3 signaling contributes to invasion in pancreatic neuroendocrine neoplasms.
Yang Y; Yang L; Li Y
Hum Pathol; 2018 Nov; 81():192-200. PubMed ID: 30420046
[TBL] [Abstract][Full Text] [Related]
28. LLL12 inhibits endogenous and exogenous interleukin-6-induced STAT3 phosphorylation in human pancreatic cancer cells.
Liu A; Liu Y; Li PK; Li C; Lin J
Anticancer Res; 2011 Jun; 31(6):2029-35. PubMed ID: 21737619
[TBL] [Abstract][Full Text] [Related]
29. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
[TBL] [Abstract][Full Text] [Related]
30. Pien Tze Huang suppresses IL-6-inducible STAT3 activation in human colon carcinoma cells through induction of SOCS3.
Shen A; Chen Y; Hong F; Lin J; Wei L; Hong Z; Sferra TJ; Peng J
Oncol Rep; 2012 Dec; 28(6):2125-30. PubMed ID: 23027374
[TBL] [Abstract][Full Text] [Related]
31. Kang-Ai Injection Inhibits Gastric Cancer Cells Proliferation through IL-6/STAT3 Pathway.
Zheng CL; Hou KZ; Wang AQ; Fang WX; Yu ST; Liang JE; Qi HY; Qu XJ; Liu YP; Che XF
Chin J Integr Med; 2022 Jun; 28(6):524-530. PubMed ID: 32648126
[TBL] [Abstract][Full Text] [Related]
32. LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation.
Liao Q; Zeng Z; Guo X; Li X; Wei F; Zhang W; Li X; Chen P; Liang F; Xiang B; Ma J; Wu M; Tang H; Deng M; Zeng X; Tang K; Xiong W; Li G
Oncogene; 2014 Apr; 33(16):2098-109. PubMed ID: 23708661
[TBL] [Abstract][Full Text] [Related]
33. IL-6/STAT3 Plays a Regulatory Role in the Interaction Between Pancreatic Stellate Cells and Cancer Cells.
Hamada S; Masamune A; Yoshida N; Takikawa T; Shimosegawa T
Dig Dis Sci; 2016 Jun; 61(6):1561-71. PubMed ID: 26738736
[TBL] [Abstract][Full Text] [Related]
34. RNAi-mediated silencing of Anxa2 inhibits breast cancer cell proliferation by downregulating cyclin D1 in STAT3-dependent pathway.
Zhang F; Wang Z; Yuan J; Wei X; Tian R; Niu R
Breast Cancer Res Treat; 2015 Sep; 153(2):263-75. PubMed ID: 26253946
[TBL] [Abstract][Full Text] [Related]
35. XZH-5 inhibits STAT3 phosphorylation and enhances the cytotoxicity of chemotherapeutic drugs in human breast and pancreatic cancer cells.
Liu A; Liu Y; Jin Z; Hu Q; Lin L; Jou D; Yang J; Xu Z; Wang H; Li C; Lin J
PLoS One; 2012; 7(10):e46624. PubMed ID: 23056374
[TBL] [Abstract][Full Text] [Related]
36. 15-Lipoxygenase-1 suppression of colitis-associated colon cancer through inhibition of the IL-6/STAT3 signaling pathway.
Mao F; Xu M; Zuo X; Yu J; Xu W; Moussalli MJ; Elias E; Li HS; Watowich SS; Shureiqi I
FASEB J; 2015 Jun; 29(6):2359-70. PubMed ID: 25713055
[TBL] [Abstract][Full Text] [Related]
37. Autocrine motility factor signaling enhances pancreatic cancer metastasis.
Tsutsumi S; Yanagawa T; Shimura T; Kuwano H; Raz A
Clin Cancer Res; 2004 Nov; 10(22):7775-84. PubMed ID: 15570012
[TBL] [Abstract][Full Text] [Related]
38. Circular RNA ANAPC7 Inhibits Tumor Growth and Muscle Wasting via PHLPP2-AKT-TGF-β Signaling Axis in Pancreatic Cancer.
Shi X; Yang J; Liu M; Zhang Y; Zhou Z; Luo W; Fung KM; Xu C; Bronze MS; Houchen CW; Li M
Gastroenterology; 2022 Jun; 162(7):2004-2017.e2. PubMed ID: 35176309
[TBL] [Abstract][Full Text] [Related]
39. β2-adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NFκB and AP-1.
Zhang D; Ma QY; Hu HT; Zhang M
Cancer Biol Ther; 2010 Jul; 10(1):19-29. PubMed ID: 20424515
[TBL] [Abstract][Full Text] [Related]
40. A role for transcription factor STAT3 signaling in oncogene smoothened-driven carcinogenesis.
Gu D; Fan Q; Zhang X; Xie J
J Biol Chem; 2012 Nov; 287(45):38356-66. PubMed ID: 22992748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
